These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

297 related items for PubMed ID: 16285959

  • 1. Silencing of caspase-8 in murine hepatocellular carcinomas is mediated via methylation of an essential promoter element.
    Liedtke C, Zschemisch NH, Cohrs A, Roskams T, Borlak J, Manns MP, Trautwein C.
    Gastroenterology; 2005 Nov; 129(5):1602-15. PubMed ID: 16285959
    [Abstract] [Full Text] [Related]

  • 2. Functional switching of TGF-beta1 signaling in liver cancer via epigenetic modulation of a single CpG site in TTP promoter.
    Sohn BH, Park IY, Lee JJ, Yang SJ, Jang YJ, Park KC, Kim DJ, Lee DC, Sohn HA, Kim TW, Yoo HS, Choi JY, Bae YS, Yeom YI.
    Gastroenterology; 2010 May; 138(5):1898-908. PubMed ID: 20038433
    [Abstract] [Full Text] [Related]

  • 3. Methylation of Tip30 promoter is associated with poor prognosis in human hepatocellular carcinoma.
    Lu B, Ma Y, Wu G, Tong X, Guo H, Liang A, Cong W, Liu C, Wang H, Wu M, Zhao J, Guo Y.
    Clin Cancer Res; 2008 Nov 15; 14(22):7405-12. PubMed ID: 19010857
    [Abstract] [Full Text] [Related]

  • 4. Aberrant epigenetic modifications in hepatocarcinogenesis induced by hepatitis B virus X protein.
    Park IY, Sohn BH, Yu E, Suh DJ, Chung YH, Lee JH, Surzycki SJ, Lee YI.
    Gastroenterology; 2007 Apr 15; 132(4):1476-94. PubMed ID: 17408664
    [Abstract] [Full Text] [Related]

  • 5. Functional promoter upstream p53 regulatory sequence of IGFBP3 that is silenced by tumor specific methylation.
    Hanafusa T, Shinji T, Shiraha H, Nouso K, Iwasaki Y, Yumoto E, Ono T, Koide N.
    BMC Cancer; 2005 Jan 20; 5():9. PubMed ID: 15661074
    [Abstract] [Full Text] [Related]

  • 6. Promoter methylation of the secreted frizzled-related protein 1 gene SFRP1 is frequent in hepatocellular carcinoma.
    Shih YL, Shyu RY, Hsieh CB, Lai HC, Liu KY, Chu TY, Lin YW.
    Cancer; 2006 Aug 01; 107(3):579-90. PubMed ID: 16795071
    [Abstract] [Full Text] [Related]

  • 7. Effects of methylation of non-CpG sequence in the promoter region on the expression of human synaptotagmin XI (syt11).
    Inoue S, Oishi M.
    Gene; 2005 Mar 28; 348():123-34. PubMed ID: 15777718
    [Abstract] [Full Text] [Related]

  • 8. Activation of Galectin-1 gene in human hepatocellular carcinoma involves methylation-sensitive complex formations at the transcriptional upstream and downstream elements.
    Kondoh N, Hada A, Ryo A, Shuda M, Arai M, Matsubara O, Kimura F, Wakatsuki T, Yamamoto M.
    Int J Oncol; 2003 Dec 28; 23(6):1575-83. PubMed ID: 14612929
    [Abstract] [Full Text] [Related]

  • 9. Epidermal growth factor-containing fibulin-like extracellular matrix protein 1, EFEMP1, a novel tumor-suppressor gene detected in hepatocellular carcinoma using double combination array analysis.
    Nomoto S, Kanda M, Okamura Y, Nishikawa Y, Qiyong L, Fujii T, Sugimoto H, Takeda S, Nakao A.
    Ann Surg Oncol; 2010 Mar 28; 17(3):923-32. PubMed ID: 19898900
    [Abstract] [Full Text] [Related]

  • 10. A novel protein-DNA interaction involved with the CpG dinucleotide at -30 upstream is linked to the DNA methylation mediated transcription silencing of the MAGE-A1 gene.
    Zhang J, Yu J, Gu J, Gao BM, Zhao YJ, Wang P, Zhang HY, De Zhu J.
    Cell Res; 2004 Aug 28; 14(4):283-94. PubMed ID: 15353125
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Sp1/Sp3 and DNA-methylation contribute to basal transcriptional activation of human podoplanin in MG63 versus Saos-2 osteoblastic cells.
    Hantusch B, Kalt R, Krieger S, Puri C, Kerjaschki D.
    BMC Mol Biol; 2007 Mar 07; 8():20. PubMed ID: 17343736
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Mapping of the methylation pattern of the MUC2 promoter in pancreatic cancer cell lines, using bisulfite genomic sequencing.
    Hamada T, Goto M, Tsutsumida H, Nomoto M, Higashi M, Sugai T, Nakamura S, Yonezawa S.
    Cancer Lett; 2005 Sep 28; 227(2):175-84. PubMed ID: 16112420
    [Abstract] [Full Text] [Related]

  • 15. Mapping the methylation pattern by bisulfite genomic sequencing of the E-cadherin promoter CpG island in nasopharyngeal carcinoma.
    Kao RH, Huang LC, Hsu YH.
    Anticancer Res; 2002 Sep 28; 22(6C):4109-13. PubMed ID: 12553040
    [Abstract] [Full Text] [Related]

  • 16. Genetic characterization of fas-associated phosphatase-1 as a putative tumor suppressor gene on chromosome 4q21.3 in hepatocellular carcinoma.
    Yeh SH, Wu DC, Tsai CY, Kuo TJ, Yu WC, Chang YS, Chen CL, Chang CF, Chen DS, Chen PJ.
    Clin Cancer Res; 2006 Feb 15; 12(4):1097-108. PubMed ID: 16489062
    [Abstract] [Full Text] [Related]

  • 17. Methylome analysis and integrative profiling of human HCCs identify novel protumorigenic factors.
    Neumann O, Kesselmeier M, Geffers R, Pellegrino R, Radlwimmer B, Hoffmann K, Ehemann V, Schemmer P, Schirmacher P, Lorenzo Bermejo J, Longerich T.
    Hepatology; 2012 Nov 15; 56(5):1817-27. PubMed ID: 22689435
    [Abstract] [Full Text] [Related]

  • 18. Promoter hypermethylation of a novel gene, ZHX2, in hepatocellular carcinoma.
    Lv Z, Zhang M, Bi J, Xu F, Hu S, Wen J.
    Am J Clin Pathol; 2006 May 15; 125(5):740-6. PubMed ID: 16707376
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.